HOLLISTON, Mass. (AP) _ Harvard Bioscience Inc. (HBIO) on Thursday reported a loss of $1.3 million in its fourth quarter.
On a per-share basis, the Holliston, Massachusetts-based company said it had a loss of 4 cents. Earnings, adjusted for non-recurring costs and stock option expense, were 4 cents per share.
The medical instruments maker posted revenue of $26.4 million in the period.
For the year, the company reported that its loss narrowed to $4.3 million, or 13 cents per share. Revenue was reported as $104.5 million.
Harvard Bioscience expects full-year earnings in the range of 15 cents to 17 cents per share.
In the final minutes of trading on Thursday, the company's shares hit $2.55. A year ago, they were trading at $2.84.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on HBIO at https://www.zacks.com/ap/HBIO
Keywords: Harvard Bioscience, Earnings Report